2024 Q1 Form 10-Q Financial Statement

#000184982024000112 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $464.4K $2.821M
YoY Change -83.54%
Cost Of Revenue $2.094M $2.932M
YoY Change -28.59% 54.4%
Gross Profit -$1.630M -$111.5K
YoY Change 1361.7% -94.13%
Gross Profit Margin -350.94% -3.95%
Selling, General & Admin $3.430M $5.210M
YoY Change -34.16% 25032.66%
% of Gross Profit
Research & Development $63.53K $227.0K
YoY Change -72.01% -82.09%
% of Gross Profit
Depreciation & Amortization $426.2K $273.1K
YoY Change 56.06% 145.33%
% of Gross Profit
Operating Expenses $63.53K $227.0K
YoY Change -72.01% -52.65%
Operating Profit -$5.549M -$5.824M
YoY Change -4.72% 116.68%
Interest Expense -$2.459M -$4.930M
YoY Change -50.13% -302.79%
% of Operating Profit
Other Income/Expense, Net $5.963M -$4.356M
YoY Change -236.9% 433.78%
Pretax Income $413.6K -$14.14M
YoY Change -102.93% -824.51%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $413.6K -$10.18M
YoY Change -104.06% -621.61%
Net Earnings / Revenue 89.07% -360.89%
Basic Earnings Per Share $0.01 -$0.26
Diluted Earnings Per Share -$0.11 -$0.26
COMMON SHARES
Basic Shares Outstanding 44.64M shares 47.28M shares
Diluted Shares Outstanding 66.74M shares 39.77M shares

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.187M $12.50M
YoY Change -50.5% 4117.56%
Cash & Equivalents $6.187M $12.48M
Short-Term Investments $0.00
Other Short-Term Assets $316.0K $54.38K
YoY Change 481.09% 20.88%
Inventory $2.215M $11.01M
Prepaid Expenses $1.580M $5.393M
Receivables $157.3K $2.635M
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.82M $32.15M
YoY Change -63.24% 9317.31%
LONG-TERM ASSETS
Property, Plant & Equipment $15.86M $16.95M
YoY Change -6.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $187.4K $140.2K
YoY Change 33.66% -99.92%
Total Long-Term Assets $17.61M $17.35M
YoY Change 1.55% -90.04%
TOTAL ASSETS
Total Short-Term Assets $11.82M $32.15M
Total Long-Term Assets $17.61M $17.35M
Total Assets $29.43M $49.49M
YoY Change -40.54% -71.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.693M $2.607M
YoY Change 156.7% 1362.33%
Accrued Expenses $6.500M $3.656M
YoY Change 77.79% 3860.0%
Deferred Revenue $478.1K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.03M $6.611M
YoY Change 112.19% 1077.18%
LONG-TERM LIABILITIES
Long-Term Debt $44.95M $16.83M
YoY Change 167.08%
Other Long-Term Liabilities $9.956M $34.93M
YoY Change -71.49% 528.18%
Total Long-Term Liabilities $54.91M $51.76M
YoY Change 6.09% 830.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.03M $6.611M
Total Long-Term Liabilities $54.91M $51.76M
Total Liabilities $68.93M $58.37M
YoY Change 18.09% 853.59%
SHAREHOLDERS EQUITY
Retained Earnings -$118.4M -$78.29M
YoY Change 51.21%
Common Stock $5.732K $4.728K
YoY Change 21.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$39.50M -$8.878M
YoY Change
Total Liabilities & Shareholders Equity $29.43M $49.49M
YoY Change -40.54% -71.65%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $413.6K -$10.18M
YoY Change -104.06% -621.61%
Depreciation, Depletion And Amortization $426.2K $273.1K
YoY Change 56.06% 145.33%
Cash From Operating Activities -$6.660M -$8.833M
YoY Change -24.6% 1704.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $68.48K $3.470M
YoY Change -98.03%
Cash From Investing Activities $68.48K $3.465M
YoY Change -98.02% -306.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $12.03M $59.19K
YoY Change 20217.13% -77.83%
NET CHANGE
Cash From Operating Activities -$6.660M -$8.833M
Cash From Investing Activities $68.48K $3.465M
Cash From Financing Activities $12.03M $59.19K
Net Change In Cash $5.434M -$5.309M
YoY Change -202.36% 2285.73%
FREE CASH FLOW
Cash From Operating Activities -$6.660M -$8.833M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2023Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2023Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2024Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2024Q1 kitt Derivative Instrument Contingent Consideration Liability Earnout Period Days Prior To Redemption
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodDaysPriorToRedemption
3 businessday
CY2024Q1 us-gaap Liabilities
Liabilities
68934417 usd
CY2023Q4 us-gaap Liabilities
Liabilities
67935325 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118378091 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118791703 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-39502929 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-41786850 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29431488 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26148475 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
464354 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2820780 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
464354 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2820780 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
2093955 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
2932267 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
426185 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
273099 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
63534 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
226967 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3430010 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5212644 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
6013684 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
8644977 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5549330 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5824197 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
96473 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1152381 usd
CY2024Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
15365 usd
CY2023Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5147 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9884 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8309623 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2236904 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2453372 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4935067 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5962942 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8314468 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
413612 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-14138665 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44635720 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39765361 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66742808 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39765361 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-41786850 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
530655 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2024Q1 kitt Stock Issued During Period Exercise Of Warrants
StockIssuedDuringPeriodExerciseOfWarrants
1339654 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
413612 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-39502929 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
27819 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1214863 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
59190 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-12836793 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
413612 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-14138665 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
426185 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
273099 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1159596 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
907865 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
142821 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2024Q1 us-gaap Accretion Expense
AccretionExpense
24212 usd
CY2023Q1 us-gaap Accretion Expense
AccretionExpense
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
530655 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1214863 usd
CY2024Q1 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-8309623 usd
CY2023Q1 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
2236904 usd
CY2024Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
115778 usd
CY2023Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
60819 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4231 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2024Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
15365 usd
CY2023Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
40737 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-55101 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1012210 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15930 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4346657 usd
CY2024Q1 us-gaap Increase Decrease In Commodity Contract Assets And Liabilities
IncreaseDecreaseInCommodityContractAssetsAndLiabilities
0 usd
CY2023Q1 us-gaap Increase Decrease In Commodity Contract Assets And Liabilities
IncreaseDecreaseInCommodityContractAssetsAndLiabilities
-249964 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1196413 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
328609 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-22133 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6193155 usd
CY2024Q1 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
-2289834 usd
CY2023Q1 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
0 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-67539 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-143729 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6660282 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8873938 usd
CY2024Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
324147 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
1493978 usd
CY2024Q1 kitt Proceeds From Sale Assets Held For Sale
ProceedsFromSaleAssetsHeldForSale
384708 usd
CY2023Q1 kitt Proceeds From Sale Assets Held For Sale
ProceedsFromSaleAssetsHeldForSale
0 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7921 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
5000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
68482 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3506022 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
13305000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1279291 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
59190 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12025709 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59190 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5433909 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5308726 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
753398 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17787159 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6187307 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12478433 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
23469 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
469850 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 kitt Interest Unpaid Capitalized
InterestUnpaidCapitalized
0 usd
CY2023Q1 kitt Interest Unpaid Capitalized
InterestUnpaidCapitalized
234985 usd
CY2024Q1 kitt Operating Leases At Inception
OperatingLeasesAtInception
1185119 usd
CY2023Q1 kitt Operating Leases At Inception
OperatingLeasesAtInception
0 usd
CY2024Q1 kitt Stock Issued During Period Exercise Of Warrants
StockIssuedDuringPeriodExerciseOfWarrants
1339654 usd
CY2023Q1 kitt Stock Issued During Period Exercise Of Warrants
StockIssuedDuringPeriodExerciseOfWarrants
0 usd
CY2024Q1 kitt Liability Held For Sale Relieved In The Period
LiabilityHeldForSaleRelievedInThePeriod
1158609 usd
CY2023Q1 kitt Liability Held For Sale Relieved In The Period
LiabilityHeldForSaleRelievedInThePeriod
0 usd
CY2024Q1 kitt Transfer From Assets Held For Sale To Property And Equipment
TransferFromAssetsHeldForSaleToPropertyAndEquipment
55642 usd
CY2023Q1 kitt Transfer From Assets Held For Sale To Property And Equipment
TransferFromAssetsHeldForSaleToPropertyAndEquipment
0 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
Description of the Business<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nauticus Robotics, Inc. (the “Company”, “our”, "us" or “we”) develops autonomous robots for the ocean industries. The Company’s principal corporate offices are located in Webster, Texas. Nauticus’ robotic systems and services are designed to address both commercial and government-facing customers. Autonomy requires the extensive use of sensors, artificial intelligence, and effective algorithms for perception and decision allowing the robot to adapt to changing environments. The Company’s business model includes using robotic systems for service, selling vehicles and components, and licensing of related software to both the commercial and defense business sectors. Nauticus has designed and is currently testing and certifying a new generation of vehicles to reduce operational cost and gather data to maintain and operate a wide variety of subsea infrastructure. Besides a standalone service offering, Nauticus’ approach to ocean robotics has also resulted in the development of a range of technology products for retrofit/upgrading legacy systems and other third-party vehicle platforms. Nauticus’ services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – The Company continues to develop its principal products and conduct research and development activities. Currently, the Company does not generate sufficient revenue to cover operating expenses, working capital and capital expenditures. The Company has embarked on cost-cutting measures to continue to preserve cash. </span><span style="background-color:#ffffff;color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may require additional liquidity to continue its operations over the next twelve months, which a current investor has committed to provide. The Company believes with this investor support that there will be sufficient resources to continue as a going concern for at least one year from the date that the condensed consolidated financial statements contained in this Form 10-Q are issued.</span></div>
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the (i) estimates of future costs to complete customer contracts recognized over time, (ii) valuation allowances for deferred income tax assets, (iii) valuation of stock-based compensation awards and (iv) the valuation of conversion options, warrants and earnouts. Actual results could differ from those estimates.
CY2024Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
50706 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
201822 usd
CY2023Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
150000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
5000000 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
40737 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
897880 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
898335 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1316846 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1300462 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
2214726 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
2198797 usd
CY2024Q1 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
780647 usd
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
1355721 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5147 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9884 usd
CY2022Q3 kitt Derivative Instrument Contingent Consideration Liability Earnout Period
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriod
P5Y
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
234985 usd
CY2023Q1 kitt Interest Costs Capitalized Inventory
InterestCostsCapitalizedInventory
95886 usd
CY2023Q1 kitt Inventory Costs Capitalized Property Plant And Equipment
InventoryCostsCapitalizedPropertyPlantAndEquipment
139099 usd
CY2024Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1090000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1090000 usd
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Financial statements presented for prior periods include reclassifications that were made to conform to the current year presentation. There was no material impact to the condensed consolidated financial statements for these changes.
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
464354 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2820780 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
157327 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
212428 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
39 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
0 usd
CY2024Q1 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
0 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
478079 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2767913 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1090000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1090000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1090000 usd
CY2024Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
970840 usd
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
876150 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
157953 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
440091 usd
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
1238803 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1282703 usd
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
182829 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
166424 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1579585 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1889218 usd
CY2024Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
695000 usd
CY2024Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
316018 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
330214 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
316018 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1025214 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2478158 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2035034 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15858895 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15904845 usd
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
2940254 usd
CY2024Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
1310832 usd
CY2024Q1 kitt Assets Held For Sale Purchase Price
AssetsHeldForSalePurchasePrice
1533609 usd
CY2024Q1 kitt Proceeds From Sale Assets Held For Sale
ProceedsFromSaleAssetsHeldForSale
375000 usd
CY2024Q1 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
425186 usd
CY2023Q4 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
618630 usd
CY2024Q1 kitt Accrued Severance Current
AccruedSeveranceCurrent
1130217 usd
CY2023Q4 kitt Accrued Severance Current
AccruedSeveranceCurrent
1375000 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
768927 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
885292 usd
CY2024Q1 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
287500 usd
CY2023Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
250000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1466433 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 usd
CY2024Q1 kitt Liability Held For Sale Not Part Of Disposal Group Current
LiabilityHeldForSaleNotPartOfDisposalGroupCurrent
0 usd
CY2023Q4 kitt Liability Held For Sale Not Part Of Disposal Group Current
LiabilityHeldForSaleNotPartOfDisposalGroupCurrent
1158609 usd
CY2024Q1 kitt Operating Lease Liability Accrued Termination Costs Current
OperatingLeaseLiabilityAccruedTerminationCostsCurrent
657000 usd
CY2023Q4 kitt Operating Lease Liability Accrued Termination Costs Current
OperatingLeaseLiabilityAccruedTerminationCostsCurrent
657000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13607 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
162697 usd
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
6500357 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7339099 usd
CY2023Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
575602 usd
CY2023Q4 kitt Asset Held For Sale Not Part Of Disposal Group Liability Current
AssetHeldForSaleNotPartOfDisposalGroupLiabilityCurrent
1158609 usd
CY2024Q1 kitt Operating Lease Liability Accrued Termination Costs Current
OperatingLeaseLiabilityAccruedTerminationCostsCurrent
657000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
62130320 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
48825320 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
15443684 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
16593357 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1788468 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
661922 usd
CY2024Q1 kitt Debt Instrument Exit Fee Provisions
DebtInstrumentExitFeeProvisions
51820 usd
CY2023Q4 kitt Debt Instrument Exit Fee Provisions
DebtInstrumentExitFeeProvisions
27608 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
44949988 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
31597649 usd
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2922425 shares
CY2022Q3 kitt Inclusive Proceeds
InclusiveProceeds
35800000 usd
CY2022Q3 kitt Fair Value Debenture Warrants
FairValueDebentureWarrants
20949110 usd
CY2022Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
21679716 usd
CY2022Q3 kitt Warrant Exercisable Share
WarrantExercisableShare
2922425 shares
CY2024Q1 kitt Convertible Secured Debentures Net
ConvertibleSecuredDebenturesNet
21086636 usd
CY2023Q4 kitt Convertible Secured Debentures Net
ConvertibleSecuredDebenturesNet
19936963 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
15443684 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
16593357 usd
CY2024Q1 us-gaap Interest Income Debt Securities Trading Operating
InterestIncomeDebtSecuritiesTradingOperating
1149672 usd
CY2023Q3 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
125000 usd
CY2023Q3 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.125
CY2023Q3 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
125000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1788468 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
661922 usd
CY2024Q1 kitt Notes Payable Exit Fee
NotesPayableExitFee
51820 usd
CY2023Q4 kitt Notes Payable Exit Fee
NotesPayableExitFee
27608 usd
CY2024Q1 kitt Debt Instrument Exit Fee Expense
DebtInstrumentExitFeeExpense
24212 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
142821 usd
CY2024Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y
CY2024Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.08
CY2023Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2023Q3 kitt Lessee Operating Lease Number Of Renewal Options
LesseeOperatingLeaseNumberOfRenewalOptions
2 option
CY2023Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.15
CY2023Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2023Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.15
CY2024Q1 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
8646527 shares
CY2022Q3 kitt Business Combination Shares
BusinessCombinationShares
279464 shares
CY2022Q3 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
3970266 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2555470 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
530655 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1214863 usd
CY2024Q1 kitt Fixed Lease Cost
FixedLeaseCost
136645 usd
CY2023Q1 kitt Fixed Lease Cost
FixedLeaseCost
102969 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
124361 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
8935 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
261006 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
111904 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
20513 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
281519 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
111904 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
147116 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
92629 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1568705 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
834972 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
356421 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
244774 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1229219 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
574260 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1585640 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
819034 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y8M12D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.126
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.143
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
366040 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
573152 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
583306 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
316110 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
53409 usd
CY2024Q1 kitt Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1892017 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
306377 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1585640 usd
CY2024Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03
CY2024Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
55003 usd
CY2023Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
117342 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57317025 shares
CY2023Q4 kitt Sale Of Stock Maximum Amount Of Shares Authorized To Be Sold
SaleOfStockMaximumAmountOfSharesAuthorizedToBeSold
5000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2
CY2022Q3 kitt Additional Share Of Common Stock
AdditionalShareOfCommonStock
7499993 shares
CY2022Q3 kitt Private Warrants Shares
PrivateWarrantsShares
8624991 shares
CY2022Q3 kitt Class Of Warrant Or Right Registration Statement Required Effective Period Within Consummation Of Business Combination
ClassOfWarrantOrRightRegistrationStatementRequiredEffectivePeriodWithinConsummationOfBusinessCombination
P120D
CY2024Q1 kitt Derivative Instrument Contingent Consideration Liability Earnout Period Minimum Prior Written Notice Required Of Redemption
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodMinimumPriorWrittenNoticeRequiredOfRedemption
30 day
CY2024Q1 kitt Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Days
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays
20 tradingday
CY2024Q1 kitt Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod
30 tradingday
CY2024Q1 kitt Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod
30 tradingday
CY2022Q3 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
11.50
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
212476 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
380531 usd
CY2024Q1 kitt Warrants And Rights Outstanding Remaining Term
WarrantsAndRightsOutstandingRemainingTerm
P3Y5M8D
CY2024Q1 kitt Class Of Warrant Or Right Registration Statement Period Required Before Closing
ClassOfWarrantOrRightRegistrationStatementPeriodRequiredBeforeClosing
P15D
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.286
CY2023Q3 us-gaap Interest Expense
InterestExpense
4320690 usd
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.95
CY2023Q3 kitt Agreed Price Per Share
AgreedPricePerShare
2.286
CY2023Q2 kitt Warrant Exercisable Share
WarrantExercisableShare
2922425 shares
CY2023Q2 kitt Aggregate Shares
AggregateShares
2922425 shares
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
165713 shares
CY2023Q2 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
165713 shares
CY2023Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
338055 usd
CY2023Q3 kitt Convertible Loan Agreement Price Per Share
ConvertibleLoanAgreementPricePerShare
6.00
CY2024Q1 kitt Stock Issued During Period Shares Exercise Of Warrant
StockIssuedDuringPeriodSharesExerciseOfWarrant
5700000 shares
CY2024Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
8197428 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.33
CY2024Q1 kitt Stock Issued During Period Shares Exercise Of Warrant
StockIssuedDuringPeriodSharesExerciseOfWarrant
5700000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
413612 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-14138665 usd
CY2024Q1 us-gaap Dilutive Securities
DilutiveSecurities
-7942330 usd
CY2023Q1 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7528718 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-14138665 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44635720 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39765361 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
434562 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
21672526 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66742808 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39765361 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
149671977 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35786241 shares
CY2024Q1 kitt Warrant Liability
WarrantLiability
8726903 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
18376180 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
1339654 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8309623 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
8726903 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001849820-24-000112-index-headers.html Edgar Link pending
0001849820-24-000112-index.html Edgar Link pending
0001849820-24-000112.txt Edgar Link pending
0001849820-24-000112-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kitt-20240331.htm Edgar Link pending
kitt-20240331.xsd Edgar Link pending
kitt-20240331xex311.htm Edgar Link pending
kitt-20240331xex312.htm Edgar Link pending
kitt-20240331xex321.htm Edgar Link pending
kitt-20240331xex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
kitt-20240331_def.xml Edgar Link unprocessable
kitt-20240331_lab.xml Edgar Link unprocessable
kitt-20240331_pre.xml Edgar Link unprocessable
kitt-20240331_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kitt-20240331_cal.xml Edgar Link unprocessable